Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AER estimates

This article was originally published in The Tan Sheet

Executive Summary

FDA revises its estimate for annual mandatory adverse event reports related to dietary supplement products to 856 from 960, based on the 214 AERs it received between Jan. 1 and April 15, according to a Sept. 15 Federal Register notice. In a separate same-day notice, FDA announces it received no comments following an October 2007 notice about information collection provisions for nonprescription drug AERs. The agency's estimate for annual serious OTC AERs will remain at 12,500 from approximately 50 respondents

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel